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Akt2/PKBbeta-sensitive regulation of renal phosphate transport
Abstract
AIM: The protein kinase B (PKB)/Akt is known to stimulate the cellular uptake of glucose and amino
acids. The kinase is expressed in proximal renal tubules. The present study explored the influence of
Akt/PKB on renal tubular phosphate transport. METHODS: The renal phosphate transporter NaPi-IIa
was expressed in Xenopus oocytes with or without PKB/Akt and Na(+) phosphate cotransport
determined using dual electrode voltage clamp. Renal phosphate excretion was determined in
Akt2/PKBbeta knockout mice (akt2(-/-)) and corresponding wild-type mice (akt2(+/+)). Transporter
protein abundance was determined using Western blotting and phosphate transport by (32)P uptake into
brush border membrane vesicles. RESULTS: The phosphate-induced current in NaPi-IIa-expressing
Xenopus oocytes was significantly increased by the coexpression of Akt/PKB. Phosphate excretion
[micromol per 24 h per g BW] was higher by 91% in akt2(-/-) than in akt2(+/+) mice. The phosphaturia
of akt2(-/-) mice occurred despite normal transport activity and expression of the renal phosphate
transporters NaPi-IIa, NaPi-IIc and Pit2 in the brush border membrane, a significantly decreased plasma
PTH concentration (by 46%) and a significantly enhanced plasma 1,25-dihydroxyvitamin D(3)
concentration (by 46%). Moreover, fractional renal Ca(2+) excretion was significantly enhanced (by
53%) and bone density significantly reduced (by 11%) in akt2(-/-) mice. CONCLUSIONS:
Akt2/PKBbeta plays a role in the acute regulation of renal phosphate transport and thus contributes to
the maintenance of phosphate balance and adequate mineralization of bone.
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Abstract:   
Aim: The protein kinase B PKB/Akt is known to stimulate the cellular uptake of glucose and 
amino acids. The kinase is expressed in proximal renal tubules. The present study explored the 
influence of Akt/PKB on renal tubular phosphate transport.  
Methods: The renal phosphate transporter NaPi-IIa was expressed in Xenopus oocytes with or 
without PKB/Akt and Na+,phosphate cotransport determined by dual electrode voltage clamp. 
Renal phosphate excretion was determined in Akt2/PKBß-knockout mice (akt2-/-) and 
corresponding wild type mice (akt2+/+). Transporter protein abundance was determined by 
western blotting and phosphate transport by 32P uptake into brush border membrane vesicles.  
Results: The phosphate-induced current in NaPi-IIa-expressing Xenopus oocytes was 
significantly increased by coexpression of Akt/PKB. Phosphate excretion (µmol/24h/[g]BW) 
was by 91% higher in akt2-/- than in akt2+/+ mice. The phosphaturia of akt2-/- mice occurred 
despite normal transport activity and expression of the renal phosphate transporters NaPi-IIa, 
NaPi-IIc, and Pit2 in the brush border membrane, a significantly decreased plasma PTH 
concentration (by 46%), and a significantly enhanced plasma 1,25-dihydroxyvitamin D3 
concentration (by 46%). Moreover, fractional renal Ca2+ excretion was significantly enhanced 
(by 53%) and bone density significantly reduced (by 11%) in akt2-/- mice.  
Conclusions: Akt2/PKBß plays a role in the acute regulation of renal phosphate transport and 
thus contributes to the maintenance of phosphate balance and adequate mineralization of bone.  
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Introduction 
 
 Phosphate participates in a multitude of cellular functions including membrane 
stabilization, energy metabolism and signaling (Berner & Shike 1988, Takeda et al. 2004). 
Beyond that, calcium phosphate is the most important component of bone minerals (Berndt & 
Kumar 2007). Precipitation of calcium phosphate in bone critically depends on local 
concentration of calcium phosphate. The latter is a function of their respective plasma 
concentrations. Reduced plasma calcium and phosphate concentrations foster demineralization 
of bone, whereas enhanced calcium and phosphate concentrations trigger calcium phosphate 
precipitations outside of bone leading to cardiovascular disease (Johnson et al. 2006) and 
accelerated ageing (Kurosu & Kuro-o M 2008). Accordingly, fine tuning of phosphate balance is 
critically important for bone mineralization on the one hand and cardiovascular integrity on the 
other. Systemic phosphate balance is a function of intestinal uptake and renal elimination (Berndt 
& Kumar 2007, Murer et al. 2000, Takeda et al. 2004). Accordingly, adequate regulation of 
renal phosphate excretion is decisive for adequate bone mineralization (Bielesz et al. 2004).  
 Renal elimination of phosphate depends on cellular uptake of phosphate across the apical 
membrane of proximal tubular cells (Forster et al. 2006). The transport is in large part accomplished 
by the Na+-coupled phosphate transporter NaPi-IIa (Forster et al. 2006, Murer et al. 2000). The carrier 
is downregulated by parathyroid hormone (PTH), which is partially effective through cAMP (Murer et 
al. 2000). Two more recently identified sodium-dependent transporters also contribute to renal 
phosphate reabsorption, NaPi-IIc and Pit-2 (Segawa et al. 2002, Villa-Bellosta et al. 2009). To date, 
only PTH and FGF23 have been identified as hormonal regulators of NaPi-IIc (Segawa et al. 2003, 
Segawa et al. 2007) whereas nothing is known about the regulation of Pit-2. Regulators of renal 
tubular phosphate transport and thus renal phosphate excretion include insulin (Allon 1992) and 
insulin-like growth factor IGF1 (Feld & Hirschberg 1996), which activate AGC kinases, such as 
Akt/PKB and SGK. Those serine/threonine kinases regulate in turn transport of glucose 
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(Dieter et al. 2004, Whiteman et al. 2002), amino acids (Green et al. 2008), Ca2+ (Koulen et 
al. 2008), H+ (Vaughan-Jones & Swietach 2008) Na+ (Lee et al. 2007) and K+ (Mannack et al. 
2008). In the kidney, Akt/PKB was implicated in the signaling of several physiological and 
pathophysiological functions including diabetic nephropathy (Menne et al. 2007, Wu et al. 
2009), glomerulonephritis (Beck et al. 2005), vasculitis (Williams et al. 2003), mesenchymal 
cell proliferation (Wagner et al. 2007), podocyte cytoskeletal architecture (Lennon et al. 
2008), polycystic kidney disease (Qian et al. 2008), transcription of 11ß-hydroxysteroid 
dehydrogenase type 2 (Balazs et al. 2008) and epithelial-to-mesenchymal transition (Zeng et 
al. 2008), but nothing is hitherto known about its putative role in renal tubular phosphate 
transport.  
 The present study addressed the putative role of Akt/PKB in the regulation of the renal 
tubular transporter NaPi-IIa. In a first step, in vitro regulation of NaPi-IIa by Akt/PKB was 
studied in the Xenopus oocyte expression system. In a second step the in vivo significance of 
Akt/PKB-sensitive phosphate transport was elucidated by analyzing gene-targeted mice 
lacking functional Akt2/PKBß (akt2-/-) as well as corresponding wild type animals (akt2+/+) 
(Cho et al. 2001b, Cho et al. 2001a). 
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Materials and Methods 
 
In vitro expression  
 For generation of cRNA, constructs were used encoding wild type NaPi-IIa (Busch et al. 
1995), constitutively active T308D,S473DAkt/PKB (Alessi et al. 1996) and inactive 
T308A,S473AAkt/PKB. The cRNA was generated as described previously (Ureche et al. 2008). 
Akt/PKB cDNA was kindly provided by Sir Philip Cohen, University of Dundee, UK, the cDNA 
encoding rat NaPi-IIa by Heini Murer, University of Zurich, Switzerland. For electrophysiology, 
Xenopus oocytes were prepared as previously described (Boehmer et al. 2008a). 5 ng of wild 
type Akt/PKB were injected on the first day and 25 ng NaPi-IIa cRNA on the second day after 
preparation of the Xenopus oocytes. All experiments were performed at room temperature 4-5 
days after the second injection. Two-electrode voltage-clamp recordings (Boehmer et al. 2008b) 
were performed at a holding potential of -60 mV. The data were filtered at 10 Hz and recorded 
with a GeneClamp 500 amplifier, a DigiData 1300 A/D-D/A converter and the pClamp 9.0 
software package for data acquisition and analysis (Axon Instruments, USA) (Laufer et al. 
2009). The control solution (superfusate / ND96) contained 96 mM NaCl, 2 mM KCl, 1.8 mM 
CaCl2, 1 mM MgCl2 and 5 mM HEPES, pH 7.4. Phosphate was added to the solutions at the 
indicated concentration. 
 The final solutions were titrated to pH 7.4 using NaOH. The flow rate of the superfusion 
was 20 ml/min and a complete exchange of the bath solution was reached within about 10 s 
(Gehring et al. 2009). Data are provided as means ± SEM, n represents the number of oocytes 
investigated. All experiments were repeated with at least 3 batches of oocytes; in all repetitions 
similar data were obtained.  
 
In vivo function 
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All animal experiments were conducted according to the guidelines of the American 
Physiological Society as well as the German law for the welfare of animals and were approved 
by local authorities. 
 The gene-targeted mice lacking functional Akt2/PKBß (akt2-/-) as well as their 
corresponding wild type animals (akt2+/+) were described previously (Cho et al. 2001b, Cho et 
al. 2001a). The mice (24 females, 20 males, age 3-5 months) were fed a control diet (C1314, 
Altromin, Lage, Germany). The mice had free access to tap drinking water.  
 For evaluation of renal excretion, both, akt2-/- and akt2+/+ mice were placed individually 
in metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24 h urine collection as 
described previously (Vallon 2003). To adapt to the new environment, the animals were allowed 
a 3 day habituation period during which food & water intake, urinary flow rate, urinary excretion 
of salt, fecal excretion and body weight were recorded every day to ascertain that the mice were 
adapted to the new environment. Subsequently, 24 h collection of urine was performed for three 
consecutive days in order to obtain the urinary parameters. To assure quantitative urine 
collection, metabolic cages were siliconized, and urine was collected under water-saturated oil. 
To obtain blood specimens, animals were lightly anesthetized with diethylether (Roth, 
Karlsruhe, Germany), and about 200 µl of blood was withdrawn into heparinized capillaries by 
puncturing the retro-orbital plexus.  
Plasma and urinary concentrations of Na+ and K+ as well as urinary Ca2+ were 
measured by flame photometry (ELEX 6361, Eppendorf, Germany). Phosphate concentration 
was determined colorimetrically utilizing commercial diagnostic kits (Roche, Mannheim, 
Germany). Plasma glucose concentration was determined utilizing a glucometer (Accutrend, 
Roche, Mannheim, Germany). Creatinine concentration in urine was determined using the 
Jaffe reaction (Sigma, St. Louis, USA), creatinine concentration in serum was measured using 
an enzymatic kit (creatinine PAP, Lehmann, Berlin, Germany) and by a photometric method 
according to the manufacturer’s instructions (dri-chem clinical chemistry analyzer FUJI FDC 
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3500i, Sysmex, Norsted, Germany). Ca2+ concentration in plasma was also determined using 
a photometric method (FUJI FDC 3500i, Sysmex, Norsted, Germany). Urinary glucose 
concentration was determined utilizing a commercial enzymatic kit (gluco-quant, Roche, 
Mannheim, Germany). Plasma intact parathormone concentration was measured using an 
ELISA kit (Immunotopics, San Clemante, USA). A radioimmunassay kit was employed to 
determine the concentration of 1,25(OH)2D3 (IDS, Boldon, UK) in plasma. The plasma insulin 
concentration was measured by using an ELISA kit (Crystal Chem, USA).  
 For the analysis of bone density, animals were sacrificed and legs were amputated and 
fixated in formalin. The samples were scanned with a high resolution microCAT-II (Siemens 
Preclinical Solutions, USA) small animal computed tomography (CT) scanner using a field of 
view of 3.1 x 3.1 x 4.8 cm³. The X-ray tube parameters were set at 80 kVp and 400 µA. The 
images were acquired with 720 angular projections (exposure time 1200 ms per projection) 
over 360 degree and binned (i.e. combining multiple pixels CCD sensor resulting in the "sum" 
on a single pixel) with a factor of two, yielding a spatial resolution of ~38 µm. The binning 
scheme is utilized when instrument data file set (IDFS) data sweeps are averaged together. It 
defines the size and spacing of the data buffers that are returned by the IDFS averaging 
routines. The total scan time was 24 minutes. Reconstructed CT images were analyzed with 
the Inveon Research Workplace software (Siemens Preclinical Solutions, USA) by drawing a 
standard-sized container around the femur and applying a region growth routine to segment 
the trabecular bone structure. For all samples, the same upper and lower density threshold was 
applied and the relative numbers of trabecular bone density compared.              
  
RNA extraction and real-time RT-PCR 
 Snap-frozen kidneys (five kidneys for each condition) were homogenized in RLT-
Buffer (Qiagen, Basel, Switzerland) and supplemented with ß-mercaptoethanol to a final 
concentration of 1%. Total RNA was extracted and reverse transcribed as described 
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previously (Nowik et al. 2008). Quantitative real-time qRT-PCR was performed on the ABI 
PRISM 7700 Sequence Detection System (Applied Biosystems). Primers for all genes of 
interest were as described (Nowik et al. 2008). For analysis of the data, the threshold was set 
to 0.06 as this value was determined to be in the linear range of the amplification curves for 
all mRNAs in all experimental runs. The expression of the gene of interest was calculated in 
relation to hypoxanthine guanine phosphoribosyl transferase (HPRT). Relative expression 
ratios were calculated as R=2(Ct(HPRT)-Ct(test gene), where Ct represents the cycle number at the 
threshold 0.06. 
 
Brush border membrane preparation (BBMV) and phosphate transport assays 
BBMV were prepared from rat kidney cortex and outer medulla using the Mg2+ 
precipitation technique as described previously (Biber et al. 1981, Biber et al. 2007). The 
phosphate transport rate into BBMVs was measured in freshly prepared BBMVs at 25°C in 
the presence of inward gradients of 100 mM NaCl or 100 mM KCl and 0.1 mM K-phosphate. 
The substrate Pi was made with 0.125 mM K2HPO4 and 32P (1 µCi/ml) to yield a final 
concentration 0.1 mM close to the expected apparent KmPi for Na+-dependent transport in 
renal BBMVs. The stop solution contained 100 mM mannitol, 5 mM Tris- HCl pH 7.4, 150 
mM NaCl, 5 mM Pi. Na+ dependence was established by incubating BBMVs in solutions in 
which KCl replaced NaCl equimolarly. Phosphate uptake was determined after 60 s, 
representing initial linear conditions, and after 120 min, to determine the equilibrium values. 
In order to distinguish between Na+-dependent Pi uptake mediated by SLC34 family members 
(e.g. NaPi-IIa and NaPi-IIc) and other Na+-dependent phosphate transporters such as SLC20 
family members (e.g. Pit-1 and Pit-2) trisodium phosphonoformic acid (PFA, final 
concentration 6 mM) added to the same solution with 107 mM NaCl was used. PFA has 
previously been shown to have a higher selectivity for SLC34 than SLC20 phosphate 
transporters at this concentration (Villa-Bellosta et al. 2009). Total protein concentration was 
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measured using the Bio–Rad Protein Assay kit, Bio–Rad, Hercules, CA, USA. 32P taken up 
by the BBMVs was determined after rapid stop of the uptake reaction by adding an ice-cold 
solution containing an excess of unlabelled phosphate, rapid filtration across filters, addition 
of 3 ml of scintillation fluid, and scintillation of filters. BBMVs were stored at −80°C until 
further use. 
 
Western blotting 
After measurement of the protein concentration (Bio-Rad, Hercules, CA), 10 µg of 
renal brush border membrane proteins were solubilized in loading buffer containing DTT and 
separated on 8% polyacrylamide gels. For immunoblotting, the proteins were transferred 
electrophoretically to polyvinylidene fluoride (PVDF) membranes (Immobilon-P, Millipore, 
Bedford, MA, USA). After blocking with 5% milk powder in Tris-buffered saline/0.1% 
Tween-20 for 60 min., the blots were incubated with the primary antibodies: rabbit polyclonal 
anti-NaPi-IIa (1:6000)(Custer et al. 1994), rabbit polyclonal anti-NaPi-IIc (1:10000) (Nowik 
et al. 2008), rabbit polyclonal anti-Pit-2 (1:3000) (kindly provided by Dr. V. Sorribas, 
University of Zaragosa, Spain) (Villa-Bellosta et al. 2009) and mouse monoclonal anti-β-actin 
antibody (42 kD; Sigma, St. Louis, MO; 1:5000) either for 2 h at room temperature or 
overnight at 4°C. Membranes were then incubated for 1 h at room temperature with secondary 
goat anti-rabbit or donkey anti-mouse antibodies 1:5000 linked to alkaline phosphatase 
(Promega, USA) or HRP (Amersham). The protein signal was detected with the appropriate 
substrates (Millipore) using the DIANA III-chemiluminescence detection system (Raytest, 
Straubenhardt, Germany). All images were analysed using the software Advanced Image Data 
Analyser AIDA, Raytest to calculate the protein of interest/β-actin ratio. As the abundance of 
ß-actin is considered to be constant, the protein of interest/β-actin ratio provides quantitative 
information about the content of the protein. 
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Statistical analysis 
Data are provided as means ± SEM, n represents the number of independent experiments. All 
data were tested for significance using paired or unpaired Student t-test or ANOVA. Where 
applicable, GraphPad InStat version 3.00 for Windows 95 (GraphPad Software, San Diego, 
USA) was used. Only results with p < 0.05 were considered statistically significant. 
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Results 
 
 The Xenopus oocyte expression system was employed to elucidate, whether Akt/PKB 
influences the major renal tubular phosphate transporter NaPi-IIa. As the carrier transports 3 
Na+ together with one phosphate, it carries excess positive charge and thus induces an inward 
current (Busch et al. 1995). Xenopus oocytes do not express significant electrogenic phosphate 
transport and thus, phosphate (3 mM) did not induce a significant current in Xenopus oocytes 
injected with water alone (Fig. 1A). In oocytes injected with cRNA encoding NaPi-IIa, 
however, the addition of phosphate (3 mM) to the bath solution induced a robust inward 
current (Ipi). Coexpression of constitutively active T308D,S473DPKB was followed by a 
significant increase in Ipi (Fig. 1A). This increase in Ipi depended on the expression of NaPi-
IIa since no significant Ipi was observed in oocytes expressing T308D,S473DPKB alone. Thus, it 
is safe to conclude that T308D,S473DPKB stimulates NaPi-IIa. Further experiments were 
performed with inactive T308A,S473APKB. As shown in Fig. 1B, inactive T308A,S473APKB failed to 
modify NaPi-IIa-dependent currents in Xenopus oocytes. Thus, PKB stimulates NaPi-IIa-
mediated Pi currents through its kinase activity. 
 To explore, whether the in vitro regulation of NaPi-IIa is relevant for renal elimination of 
phosphate in vivo, metabolic cage experiments were performed in gene-targeted mice lacking 
functional Akt2/PKBß (akt2-/-) and their corresponding wild type animals (akt2+/+). As listed 
in Table 1, the body weight was significantly higher (by 17%) in akt2-/-  than in akt2+/+ mice. 
Along those lines, defective PKB/Akt has previously been shown to favor the development of 
obesity in humans (Farese et al. 2005). 
 As reported earlier (Cho et al. 2001b, Cho et al. 2001a), the plasma glucose 
concentration in non-fasted animals was significantly higher (by 87%) in akt2-/- than in akt2+/+ 
mice (Table 1). The hyperglycemia was secondary to insulin resistance, as plasma insulin 
concentration was significantly higher (by 300%) in akt2-/- mice than in akt2+/+ mice (Table 1). 
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Under fasting conditions, plasma glucose concentration tended to be higher in akt2-/- mice than in 
akt2+/+ mice, a difference, however, not reaching statistical significance.  
 Plasma Na+ concentration was significantly higher (by 7%) and plasma K+ concentration 
was significantly lower (by 11%) in akt2-/- mice than in akt2+/+ mice. Urinary flow rate was 
significantly larger in akt2-/- mice than in akt2+/+ mice. Urinary excretions of Na+ (by 64%) and 
K+ (by 44%) were slightly, but again significantly larger in akt2-/- mice than in akt2+/+ mice.  
 Akt2-/- mice excreted significantly larger amounts of phosphate (by 44%) and Ca2+ (by 
34%) than akt2+/+ mice. Accordingly, the Ca2+ (by 75%) and phosphate (by 91%) excretion per 
gram body weight was again significantly larger in akt2-/- than in akt2+/+ mice (Table 1). 
Moreover, the fractional phosphate excretion was significantly higher (by 100%) in akt2-/- than in 
akt2+/+ mice (Table 1).  
 A separate evaluation of female and male mice revealed that plasma phosphate 
concentration was significantly lower (by 33%) in female akt2-/- than in female akt2+/+ mice, but 
that the urinary phosphate excretion was not significantly different between female akt2-/- and 
female akt2+/+ mice. Plasma phosphate concentration was not significantly different between 
male akt2-/- and male akt2+/+ mice, but urinary phosphate excretion was significantly higher in 
male akt2-/- than in male akt2+/+ mice (not shown).  
The differences in mineral excretion between  akt2-/-  and akt2+/+ mice could have been 
due to altered hormone release. Thus, plasma concentrations of PTH and 1,25(OH)2D3 were 
determined. As illustrated in Fig. 2, the PTH plasma concentration was significantly lower (by 
46%) (Fig. 2A) and the plasma 1,25(OH)2D3 concentration (Fig. 2B) was significantly higher (by 
46%) in akt2-/- than in akt2+/+ mice.  
The fasting insulin levels were significantly (by 300%) increased in the akt2-/- mice 
(137.8 ± 17.2 pM, n = 8) compared to the akt2+/+ mice (34.4 ± 17.2. pM, n = 7). 
 In a further series of experiments we assessed the impact of Akt/PKB ablation on total 
kidney mRNA abundance and brush border membrane protein expression of the three known 
Page 12 of 32Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 13 
renal phosphate cotransporters NaPi-IIa, NaPi-IIc, and Pit-2. Pit-1 is also expressed in kidney but 
its function and exact localization are unknown. Semiquantitative real-time RT-PCR did not 
reveal significant differences in the mRNA abundance of any of the phosphate transporters 
between akt2-/-  and akt2+/+ mice (Fig. 3). Similarly, Western blotting did not show any 
difference in brush border membrane protein expression (Fig. 4). Moreover, the total sodium-
dependent uptake of phosphate into isolated brush border membrane vesicles was similar in 
akt+/+ and akt-/- mice (Fig. 5). Phosphate transport by NaPi-IIa and NaPi-IIc but not by Pit-2 is 
sensitive to phosphonoformic acid (PFA) and thus PFA can be used to distinguish between NaPi-
IIa- and NaPi-IIc- or Pit-2-related transport activities (Villa-Bellosta et al. 2009). PFA-resistant 
sodium-dependent phosphate transport (i.e. mediated by Pit-2) was again not significantly 
different between the genotypes.  
 Renal loss of calcium and phosphate were expected to foster demineralization of bone. 
Thus, bone density was determined in akt2-/- and akt2+/+ mice. As illustrated in Fig. 6, the bone 
density was indeed lower (by 11%) in akt2-/- than in akt2+/+ mice.  
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Discussion 
 
 The present study reveals a completely novel function of Akt2/PKBß, i.e. the regulation 
of renal tubular phosphate transport. The Xenopus oocyte experiments revealed that coexpression 
of constitutively active T308D,S473DPKB led to a marked increase in NaPi-IIa activity. Accordingly, 
renal phosphate excretion was significantly larger (by 91%) in Akt2/PKBß knockout mice (akt2-
/-) than in the corresponding wild type animals (akt2+/+), a finding which discloses the in vivo 
significance of Akt2/PKBß-sensitive renal tubular phosphate transport.  
 The phosphaturia could have partially been due to glucosuria, leading to impairment of 
renal water and electrolyte excretion. Alternatively both, glucosuria and phosphaturia in akt2-/-
mice could have resulted in part from decreased driving force, e.g. due to impaired function of 
the Na+/K+ ATPase. Along those lines, renal Na+ excretion was significantly higher and 
fractional Na+ excretion tended to be higher in akt2-/- than in akt2+/+ mice. It is noteworthy, 
however, that, the difference between the genotypes was clearly more pronounced in the 
fractional phosphate excretion than in the fractional Na+ excretion.  
 The phosphaturia of akt2-/- mice cannot be explained by increased plasma phosphate 
concentration, which is not significantly different between the genotypes if males and female 
mice are evaluated together. In female akt2-/- mice the plasma phosphate concentration was 
significantly lower, whereas in male akt2-/- mice the urinary phosphate excretion was 
significantly higher than in the respective akt2+/+ mice. Those observations could point to a 
subtle gender difference, i.e. the ability of male, but not of female animals to prevent a decline of 
plasma phosphate concentration during urinary phosphate wasting. Along those lines, androgens 
stimulate mineral transport in the intestine (Hope et al. 1992). However, the present data do not 
allow safe conclusions as to differences between males and females during PKB/Akt deficiency. 
 The phosphaturia of akt2-/- mice contrasts the decreased plasma level of PTH, the major 
regulator of renal phosphate transport (Murer et al. 2000). PTH promotes internalization and 
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subsequent degradation of NaPi-IIa (Murer et al. 2000) thus leading to phosphaturia and 
decrease of plasma phosphate concentration. An increased plasma PTH concentration was 
thus expected to enhance renal phosphate excretion and to increase plasma phosphate 
concentration. Instead, PTH plasma levels were significantly decreased in akt2-/- mice. As an 
increase in plasma phosphate concentration is known to inhibit PTH release (Martin et al. 
2005), the renal loss of phosphate may be expected to increase plasma PTH concentration. 
PTH stimulates renal tubular Ca2+ reabsorption (Friedman 2000). Thus, the decreased plasma 
PTH concentration could contribute to or even account for the calciuria in akt2-/- mice.  
 Plasma 1,25(OH)2D3 concentration was significantly enhanced in akt2-/- mice. The 
increased plasma 1,25(OH)2D3 concentration cannot be secondary to altered PTH plasma 
concentration, as PTH is a powerful stimulator of renal 1α-hydroxylase (Portale & Miller 
2000), the rate-limiting enzyme of 1,25(OH)2D3 formation (Kato 1999, Portale & Miller 
2000). Instead, the enhanced formation of 1,25(OH)2D3 may rather be the result of impaired 
cellular phosphate uptake by proximal tubule cells of akt2-/- mice, since cellular phosphate 
depletion stimulates the renal 1α-hydroxylase (Perwad et al. 2005).  
As 1,25(OH)2D3 is a powerful stimulator of intestinal phosphate and calcium transport 
(Brown et al. 2002), the enhanced plasma 1,25(OH)2D3 concentration is expected to increase 
intestinal phosphate and calcium uptake and thus to blunt the effect of renal phosphate and 
calcium loss on plasma phosphate and calcium concentration.  
Renal phosphate transporter expression and activity ex vivo were not significantly 
different between wildtype and Akt2/PKBß-deficient mice. The discrepancy between the in vivo 
phosphaturia and the lack of differences in phosphate transport across isolated brush border 
vesicles could reflect an effect of Akt2/PKBß on the activity of NaPi-IIa, which is lost upon 
isolation of the brush border vesicles. A discrepancy between transport across isolated brush 
border membranes and renal clearance could further result from an indirect impairment of renal 
tubular phosphate transport, e.g. by decreased Na+/K+ ATPase activity (see above). It should 
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further be kept in mind that lower PTH levels are expected to increase NaPi-IIa abundance 
(Kempson et al. 1995). The fact that we found comparable levels of NaPi-IIa, NaPi-IIc, and 
Pit-2 expression in both genotypes despite lower PTH plasma levels in the Akt2/PKBß-
deficient mice may suggest that the decrease of NaPi-IIa expression due to lack of Akt2/PKBß is 
concealed by a compensatory increase due to the  low PTH levels. Whatever mechanism 
involved, our data clearly demonstrate an impact of Akt2/PKBß-dependent signalling on renal 
phosphate clearance. 
Despite the decreased PTH plasma concentration and the enhanced 1,25(OH)2D3 
concentration in blood, akt2-/- mice suffer from a subtle but significant impairment of bone 
mass. Thus, the renal Ca2+ and phosphate loss occurs apparently in part at the expense of bone 
minerals. Phosphate inhibits the generation of new osteoclasts and fosters apoptosis of mature 
osteoclasts (Kanatani et al. 2003). Accordingly, renal phosphate loss is expected to foster 
bone resorption. The present observations cannot rule out a more direct role of Akt2/PKBß in 
bone mineralization. Akt2/PKBß was implicated in the survival of both osteoblasts 
(Chaudhary & Hruska 2001) and osteoclasts (Kwak et al. 2008, Lee et al. 2001). Lack of the 
phosphatase PTEN, which leads to excessive PI3 kinase signalling, has previously been 
shown to stimulate bone mineralization (Liu et al. 2007). Thus, the PI3 kinase/PKB/Akt 
pathway apparently serves to enhance bone mineralization. It is tempting to speculate that this 
function similarly involves PKB/Akt-sensitive upregulation of  phosphate transport.   
In conclusion, Akt2/PKBß contributes to the regulation of renal tubular phosphate 
transport. Lack of Akt2/PKBß leads to renal phosphate wasting, which presumably 
contributes to or even accounts for a decreased PTH release with resulting calciuria, increased 
formation of 1,25(OH)2D3 and decreased mineralization of bone. The present observations 
thus disclose a novel player in the regulation of phosphate metabolism. 
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Table 1: Analysis of blood and urine of akt2-/- and akt2+/+ mice 
Body weight, packed cell volume (haematocrit), plasma insulin levels, unfasting and fasting 
plasma glucose concentration as well as urinary glucose excretion, Na+, K+, Ca2+ and phosphate 
concentration in plasma, urinary flow rate, renal excretions of Na+, K+, Ca2+ and phosphate, 
creatinine clearance and fractional renal excretions of Na+, K+, Ca2+ and phosphate in both 
Akt2/PKBß knockout mice (akt2-/-, n = 11) and their corresponding wild type animals (akt2+/+, 
n = 9). Arithmetic means ± SEM (number of animals studied); * indicates significant difference 
between genotypes (p<0.05). 
 
 akt2-/- akt2+/+ 
Body Weight (g) 26.0 ± 0.5 * 22.3 ± 1.1 
Haematocrit (%) 50.1 ± 1.0 46.7 ± 3.4 
Plasma insulin (pM) 137.8 ± 17.2* 34.4± 17.2  
Unfasting plasma glucose (mM) 14.2 ± 2.1* 7.6 ± 0.4 
Fasting plasma glucose (mM) 4.7 ± 1.1  4.1 ± 0.4 
Urinary glucose (µmol/24h/g BW) 0.25 ± 0.10* 0.01 ± 0.01 
[Na+]plasma (mM) 155.0 ± 2.3* 145.2 ± 4.4 
[K+]plasma (mM) 3.3 ± 0.1* 3.7 ± 0.16 
[Ca2+]plasma (mM) 2.6 ± 0.1 2.5 ± 0.1 
[Pi]plasma (mM) 0.96 ± 0.04 0.97 ± 0.06 
Urinary flow rate (µl/24h/g BW) 86.7 ± 11.0* 27.5 ± 4.6 
Urine Na+ (µmol/24h/g BW) 1.8 ± 0.2 * 1.1 ± 0.1 
Urine K+ (µmol/24h/g BW) 5.9 ± 0.7 * 4.1 ± 0.4 
Urine Ca2+ (µmol/24h/g BW ) 0.11 ± 0.02 * 0.04 ± 0.01 
Urine Pi (µmol/24h/g BW ) 1.01 ± 0.12 * 0.53 ± 0.15 
Creatinine clearance (µl/min/g BW) 7.2 ± 1.2 6.1 ± 1.5 
Fractional excretion Na+ (%) 0.14 ± 0.03 0.11 ± 0.02 
Fractional excretion K+ (%) 20.4 ± 3.5 16.1 ± 3.0 
Fractional excretion Ca2+ (%) 0.52 ± 0.08 0.34 ± 0.06 
Fractional excretion Pi (%) 4.8 ± 0.8* 2.4 ± 0.7 
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Figure Legends  
 
Fig. 1: Coexpression of Akt/PKB stimulates electrogenic phosphate transport in NaPi-
IIa expressing Xenopus oocytes 
A. Arithmetic means ± SEM of phosphate (3 mM)-induced normalized currents (IPi) in 
Xenopus oocytes injected with water without (left bars, n = 9), or with (right bars, n = 9) 
NaPi-IIa without (open bars, n = 18) or with (closed bars, n = 18) additional coexpression of 
constitutively active T308D,S473DPKB. * indicates statistically significant difference from current 
in Xenopus oocytes expressing NaPi-IIa alone. 
B. Arithmetic means ± SEM (n = 7-20) of phosphate (3 mM)-induced currents (IPi) in 
Xenopus oocytes injected with water (1st bar) or with NaPi-IIa without (2nd bar) or with 
additional coexpression of constitutively active T308D,S473DPKB (3rd bar) or of inactive 
T308A,S473APKB (4th bar). *** indicates statistically significant difference from current in 
Xenopus oocytes expressing NaPi-IIa alone. 
 
Fig. 2: Plasma PTH and 1,25(OH)2D3 concentrations in akt2-/- and akt2+/+ mice 
Arithmetic means ± SEM of PTH (A) and 1,25(OH)2D3 (B) (n = 10-12 each group) 
concentrations in Akt2/PKBß knockout mice (akt2-/-, closed bars) and corresponding wild type 
animals (akt2+/+, open bars).* p<0.05 vs. respective value of akt2+/+ mice 
 
Fig. 3: Renal mRNA expression of phosphate transporters 
Arithmetic means ± SEM (n = 5 each group) of relative mRNA expression of phosphate 
transporters in the kidneys from Akt2/PKBß knockout mice (akt-/-, closed bars) and 
corresponding wildtype animals (akt+/+, open bars). No significant differences were found 
between genotypes. 
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Fig. 4: Brush border membrane expression of phosphate transporters 
Western blots of brush border membranes for the renal phosphate transporters NaPi-IIa and 
NaPi-IIc, and Pit-2. Membranes were stripped and reprobed for β-actin. Summary of 
densitometric analyses of Western blots are shown after normalization of the protein of 
interests against β-actin as arithmetic means ± SEM (n = 5-6 each group). No significant 
differences were found between genotypes. 
 
Fig. 5: Sodium-dependent phosphate transport activities in brush border membrane 
vesicles 
Arithmetic means ± SEM (n = 5-6 each group) of total and PFA-resistant (6 mM PFA) 
sodium-dependent phosphate transport activities (1 min) into brush border membrane vesicles 
prepared from kidneys from Akt2/PKBß knockout mice (akt-/-, closed bars) and corresponding 
wildtype animals (akt+/+, open bars). No significant differences were found between 
genotypes. 
 
Fig. 6: Bone density of akt2-/- and akt2+/+ mice  
Arithmetic means ± SEM (n = 6 each group) of bone density in Akt2/PKBß knockout mice 
(akt2-/-, closed bars) and corresponding wild type animals (akt2+/+, open bars).* p<0.05 vs. 
respective value of akt2+/+ mice. 
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